We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$194M
AUM Growth
-$4.43M
Cap. Flow
+$38.3M
Cap. Flow %
19.78%
Top 10 Hldgs %
32.5%
Holding
489
New
146
Increased
58
Reduced
57
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 12.38%
2 Industrials 11.28%
3 Consumer Discretionary 9.78%
4 Healthcare 9.65%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FJP icon
276
First Trust Japan AlphaDEX Fund
FJP
$249M
$14K 0.01%
+300
New +$14.6K
FXD icon
277
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$269M
$14K 0.01%
+400
New +$14.2K
MCK icon
278
McKesson
MCK
$100B
$14K 0.01%
+100
New +$14.7K
PRGO icon
279
Perrigo
PRGO
$1.4B
$14K 0.01%
171
VLO icon
280
Valero Energy
VLO
$90.1B
$14K 0.01%
200
+182
+1,011% +$11.2K
WPM icon
281
Wheaton Precious Metals
WPM
$49.5B
$14K 0.01%
700
-300
-30% -$6.25K
ZBRA icon
282
Zebra Technologies
ZBRA
$14B
$14K 0.01%
163
MSFG
283
DELISTED
MainSource Financial Group Inc
MSFG
$14K 0.01%
400
-226
-36% -$6.51K
CMCSA icon
284
Comcast
CMCSA
$85B
$13K 0.01%
+384
New +$12.8K
DEM icon
285
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.9B
$13K 0.01%
350
DGS icon
286
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.69B
$13K 0.01%
325
HEDJ icon
287
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$13K 0.01%
+450
New +$12.3K
TVRD
288
Tvardi Therapeutics
TVRD
$19.7M
$13K 0.01%
40
ASH icon
289
Ashland
ASH
$3.33B
$12K 0.01%
217
BKH icon
290
Black Hills Corp
BKH
$5.42B
$12K 0.01%
200
CCK icon
291
Crown Holdings
CCK
$12.8B
$12K 0.01%
+230
New +$12.4K
FXL icon
292
First Trust Technology AlphaDEX Fund
FXL
$2.53B
$12K 0.01%
+326
New +$12.1K
HSBC icon
293
HSBC
HSBC
$365B
$12K 0.01%
+332
New +$11.8K
HYS icon
294
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
$12K 0.01%
+120
New +$11.9K
REGN icon
295
Regeneron Pharmaceuticals
REGN
$78.5B
$12K 0.01%
33
SCHH icon
296
Schwab US REIT ETF
SCHH
$11.5B
$12K 0.01%
+600
New +$12K
ACWV icon
297
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.32B
$11K 0.01%
+150
New +$11K
CWB icon
298
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.6B
$11K 0.01%
+233
New +$10.6K
EPD icon
299
Enterprise Products Partners
EPD
$82.3B
$11K 0.01%
389
RTX icon
300
RTX Corp
RTX
$290B
$11K 0.01%
159

Similar funds

AlphaMark Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, AlphaMark Advisors held 489 positions worth $194M, down 2.2% from $198M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

AlphaMark Advisors deployed $38.3M of net new capital in Q4 2016, opening 146 new positions and adding to 58 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 200 shares worth $488K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $2.79M trimmed.

  • AlphaMark Advisors's largest Q4 2016 buy was Berkshire Hathaway Class A: 200 shares worth $488K.
  • AlphaMark Advisors added most to iShares iBonds Dec 2018 Term Corporate ETF in Q4 2016, an estimated $1.41M increase.
  • AlphaMark Advisors's biggest Q4 2016 reduction was Jazz Pharmaceuticals, cutting an estimated $2.79M.
  • AlphaMark Advisors fully exited Wabash National in Q4 2016, selling an estimated $939K.
  • AlphaMark Advisors's ten largest holdings make up 33% of its $194M portfolio in Q4 2016.
  • AlphaMark Advisors opened 146 new positions and closed 22 in Q4 2016.
  • AlphaMark Advisors's portfolio value fell 2.2% quarter-over-quarter to $194M.

Based on AlphaMark Advisors's 13F filing for Q4 2016, filed 26 Jan 2017.